Dactolisib tosylate is a potent compound that inhibits PI3 kinase activity. It targets Autophagy, mTOR, mTORC1, mTORC2, p110α, p110α-E545K, p110α-H1047R, p110β, p110δ, and p110γ.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.